ITFI920071A1 - Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk - Google Patents

Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk

Info

Publication number
ITFI920071A1
ITFI920071A1 IT000071A ITFI920071A ITFI920071A1 IT FI920071 A1 ITFI920071 A1 IT FI920071A1 IT 000071 A IT000071 A IT 000071A IT FI920071 A ITFI920071 A IT FI920071A IT FI920071 A1 ITFI920071 A1 IT FI920071A1
Authority
IT
Italy
Prior art keywords
vqgeesndk
sequence
peptide represented
recombinant antigens
increased immunogenicity
Prior art date
Application number
IT000071A
Other languages
English (en)
Inventor
Paolo Ghiara
Luigi Villa
Original Assignee
Istituto Ricerche Immunobiologiche Siena S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Ricerche Immunobiologiche Siena S R L filed Critical Istituto Ricerche Immunobiologiche Siena S R L
Priority to ITFI920071A priority Critical patent/IT1262898B/it
Publication of ITFI920071A0 publication Critical patent/ITFI920071A0/it
Priority to AU37510/93A priority patent/AU3751093A/en
Priority to JP5516285A priority patent/JPH07507447A/ja
Priority to PCT/EP1993/000685 priority patent/WO1993019185A1/en
Priority to CA002132420A priority patent/CA2132420A1/en
Priority to EP93906579A priority patent/EP0637337A1/en
Publication of ITFI920071A1 publication Critical patent/ITFI920071A1/it
Application granted granted Critical
Publication of IT1262898B publication Critical patent/IT1262898B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ITFI920071A 1992-03-23 1992-03-23 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk IT1262898B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITFI920071A IT1262898B (it) 1992-03-23 1992-03-23 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk
AU37510/93A AU3751093A (en) 1992-03-23 1993-03-19 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine
JP5516285A JPH07507447A (ja) 1992-03-23 1993-03-22 異種の免疫刺激ドメインをその配列内に含む組換え抗原−ワクチンとしてのその使用
PCT/EP1993/000685 WO1993019185A1 (en) 1992-03-23 1993-03-22 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine
CA002132420A CA2132420A1 (en) 1992-03-23 1993-03-22 Recombinant antigen containing in its sequence a heterologous immuno-stimulatory domain-use as a vaccine
EP93906579A EP0637337A1 (en) 1992-03-23 1993-03-22 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920071A IT1262898B (it) 1992-03-23 1992-03-23 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk

Publications (3)

Publication Number Publication Date
ITFI920071A0 ITFI920071A0 (it) 1992-03-23
ITFI920071A1 true ITFI920071A1 (it) 1993-09-23
IT1262898B IT1262898B (it) 1996-07-22

Family

ID=11350020

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI920071A IT1262898B (it) 1992-03-23 1992-03-23 Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk

Country Status (6)

Country Link
EP (1) EP0637337A1 (it)
JP (1) JPH07507447A (it)
AU (1) AU3751093A (it)
CA (1) CA2132420A1 (it)
IT (1) IT1262898B (it)
WO (1) WO1993019185A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6639198A (en) 1997-03-07 1998-09-22 Dsm N.V. Radiation-curable composition having high cure speed
JP2023545009A (ja) * 2020-10-02 2023-10-26 イムノン、インコーポレイテッド ポリヌクレオチドワクチンおよびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217314B (it) * 1987-02-20 1990-03-22 Sclavo Spa Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
NZ235315A (en) * 1989-09-19 1991-09-25 Wellcome Found Chimaeric hepadnavirus core antigen proteins and their construction
AU7683391A (en) * 1990-04-27 1991-11-27 Upjohn Company, The Modified interleukin-1 inhibitors

Also Published As

Publication number Publication date
AU3751093A (en) 1993-10-21
ITFI920071A0 (it) 1992-03-23
CA2132420A1 (en) 1993-09-24
WO1993019185A1 (en) 1993-09-30
IT1262898B (it) 1996-07-22
JPH07507447A (ja) 1995-08-24
EP0637337A1 (en) 1995-02-08

Similar Documents

Publication Publication Date Title
ATA257190A (de) Virales polypeptid
DE4393381T1 (de) Peptide
NO942066L (no) Peptidderivater
FI921740A (fi) Hybrid polypeptid
DE3789413T2 (de) Lymphokin-ähnliche Peptide.
NO982550D0 (no) 1L-13 reseptor polypeptid
GB2279077B (en) Therapeutic compositions comprising recombinant antibodies specific for the TNFalpha
DK162890D0 (da) Polypeptid
FI945085A (fi) Yhdistelmä-neu-reseptoristimulaatiotekijä
HU912526D0 (en) Recombinant marek-type disease virus
EP0440351A3 (en) Recombinant human anti-cd18 antibodies
EP0438312A3 (en) Recombinant human anti-cd18 antibodies
EP0448099A3 (en) Novel peptides
DK551287A (da) Polypeptid
DK354389D0 (da) Polypeptid
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
ITFI920071A0 (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vogeesndk
MC1964A1 (fr) Peptides regulateurs de l'appetit
EP0600000A4 (en) HEPATITIS C DETECTION TEST USING RECOMBINANT ANTIGENS OF THE NS5 REGION.
DE3685636D1 (de) Lysozymbetreffende peptide.
DE69420044D1 (de) Blutregulierende peptide
EP0580758A4 (en) RECOMBINANT ANTI-HIV ANTIBODIES.
GB9106568D0 (en) Recombinant antigen
IT8819790A0 (it) Peptidi ad attivita' farmaceutica.
DK236190D0 (da) Polypeptid

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970325